\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	the\\ patient\\'s\\ skin\\ was\\ extremely\\ taut\\ with\\ marked\\,\\ non\\-pitting\\,\\ symmetric\\ induration\\ over\\ his\\ cheeks\\,\\ lateral\\ and\\ posterior\\ neck\\,\\ chest\\,\\ upper\\ back\\ and\\ shoulders\\ extending\\ down\\ the\\ upper\\ arms\\,\\ abdomen\\,\\ and\\ upper\\ anterior\\ and\\ lateral\\ thighs\\.\\ there\\ was\\ no\\ sharp\\ line\\ of\\ demarcation\\ noted\\ between\\ involved\\ and\\ uninvolved\\ areas\\.\\ there\\ was\\ no\\ tenderness\\,\\ and\\ he\\ maintained\\ full\\ range\\ of\\ motion\\.\\ his\\ hands\\,\\ buttocks\\,\\ and\\ lower\\ legs\\ were\\ spared\\.\\ also\\ noted\\ were\\ diffuse\\ follicular\\ papules\\ and\\ perifollicular\\ erythema\\ over\\ his\\ cheeks\\,\\ neck\\,\\ upper\\ back\\,\\ upper\\ arms\\,\\ and\\ upper\\ chest\\.\\ heart\\ sounds\\ were\\ normal\\.\\ speech\\ and\\ swallowing\\ was\\ normal\\.\\ \ \(0\)\
\-\ laboratory\\:\\ normal\\ fasting\\ glucose\\.\\ elevated\\ aso\\ titer\\;\\ documented\\ positive\\ beta\\-streptococcal\\ throat\\ culture\\.\\ normal\\ cbc\\ without\\ eosinophilia\\;\\ normal\\ electrolytes\\,\\ liver\\ enzymes\\,\\ bun\\,\\ creatinine\\.\\ normal\\ aldolase\\ and\\ creatinine\\ kinase\\.\\ normal\\ esr\\;\\ ana\\ negative\\.\\ serum\\ protein\\ electrophoresis\\ \\(spep\\)\\ normal\\ with\\ no\\ evidence\\ of\\ monoclonal\\ peaks\\.\\ normal\\ electrocardiogram\\.\ \(0\)\
\-\ histopathology\\:\\ incisional\\ biopsy\\,\\ left\\ posterior\\ upper\\ arm\\:\\ extremely\\ thickened\\ dermis\\ with\\ thick\\,\\ non\\-hyalinized\\ collagen\\ bundles\\ separated\\ by\\ large\\ interfascicular\\ spaces\\;\\ sweat\\ glands\\ were\\ seen\\ in\\ the\\ mid\\-dermis\\.\\ there\\ were\\ decreased\\ numbers\\ of\\ fibroblasts\\.\\ special\\ stains\\ for\\ mucin\\ \\(colloidal\\ iron\\)\\ revealed\\ evidence\\ of\\ increased\\ mucopolysaccharides\\.\\ findings\\ were\\ consistent\\ with\\ scleredema\\.\ \(0\)\
\-\ no\\ definitive\\ treatment\\ is\\ available\\ and\\ the\\ patient\\ was\\ monitored\\ clinically\\.\\ there\\ was\\ slight\\ softening\\ two\\ months\\ after\\ initial\\ presentation\\.\\ on\\ phone\\ contact\\ five\\ months\\ later\\,\\ the\\ patient\\ reported\\ no\\ worsening\\,\\ but\\ no\\ significant\\ improvement\\.\ \(0\)\
\-\ scleredema\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#23\\)\\ presented\\ by\\:\\ jay\\ l\\.\\ viernes\\,\\ maj\\,\\ usaf\\,\\ mc\\,\\ fs\ \(0\)\
\-\ presented\\ complaining\\ of\\ a\\ two\\ month\\ history\\ of\\ increasing\\ tightness\\ of\\ his\\ skin\\ overlying\\ his\\ cheeks\\,\\ neck\\,\\ chest\\,\\ shoulders\\,\\ back\\,\\ upper\\ arms\\,\\ abdomen\\,\\ and\\ thighs\\.\\ he\\ reported\\ no\\ involvement\\ of\\ his\\ hands\\,\\ lower\\ legs\\ and\\ feet\\.\\ he\\ had\\ been\\ able\\ to\\ continue\\ performing\\ regular\\ physical\\ fitness\\ activities\\,\\ but\\ was\\ noting\\ increasing\\ difficulty\\ due\\ to\\ the\\ tightening\\ around\\ his\\ shoulders\\ and\\ neck\\.\\ the\\ patient\\ reported\\ having\\ a\\ history\\ of\\ infectious\\ mononucleosis\\ followed\\ by\\ a\\ beta\\ hemolytic\\ strep\\ throat\\ infection\\ approximately\\ six\\ to\\ eight\\ weeks\\ before\\ noting\\ his\\ skin\\ tightening\\.\\ the\\ patient\\ was\\ otherwise\\ healthy\\.\\ he\\ denied\\ any\\ family\\ history\\ of\\ diabetes\\ or\\ connective\\ tissue\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cheeks\\:\\ 0\\.046607703145283653\ \(0\)\
\-\ his\\:\\ 0\\.04625143713890952\ \(0\)\
\-\ scleredema\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ upper\\:\\ 0\\.03872451653274588\ \(0\)\
\-\ tightening\\:\\ 0\\.03813319832585236\ \(0\)\
\-\ shoulders\\:\\ 0\\.036464311720000794\ \(0\)\
\-\ arms\\:\\ 0\\.03360892363473203\ \(0\)\
\-\ thighs\\:\\ 0\\.029345394678427048\ \(0\)\
\-\ noting\\:\\ 0\\.028673559731757222\ \(0\)\
\-\ normal\\:\\ 0\\.028301671576037347\ \(0\)\
\-\ were\\:\\ 0\\.027327976573097483\ \(0\)\
\-\ neck\\:\\ 0\\.023560968422708755\ \(0\)\
\-\ skin\\:\\ 0\\.023113584050978717\ \(0\)\
\-\ throat\\:\\ 0\\.022928135170151045\ \(0\)\
\-\ extremely\\:\\ 0\\.022836970447817233\ \(0\)\
\-\ creatinine\\:\\ 0\\.022836970447817233\ \(0\)\
\-\ he\\:\\ 0\\.022386735605943845\ \(0\)\
\-\ \\,\\:\\ 0\\.022241437307758353\ \(0\)\
\-\ reported\\:\\ 0\\.02193714683504093\ \(0\)\
\-\ legs\\:\\ 0\\.02171766986826325\ \(0\)\
\-\ hands\\:\\ 0\\.020756193752554268\ \(0\)\
\-\ beta\\-streptococcal\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ non\\-hyalinized\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ interfascicular\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ mid\\-dermis\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ back\\:\\ 0\\.019852579826390684\ \(0\)\
\-\ taut\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ non\\-pitting\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ perifollicular\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ aso\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ aldolase\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ colloidal\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ mucopolysaccharides\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ viernes\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ \\;\\:\\ 0\\.01901803932819337\ \(0\)\
\-\ was\\:\\ 0\\.01855920229509271\ \(0\)\
\-\ jay\\:\\ 0\\.018114803134503258\ \(0\)\
\-\ uninvolved\\:\\ 0\\.017439493105273728\ \(0\)\
\-\ demarcation\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ softening\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ phone\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ fitness\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ electrophoresis\\:\\ 0\\.016487697076850806\ \(0\)\
\-\ spep\\:\\ 0\\.016487697076850806\ \(0\)\
\-\ electrocardiogram\\:\\ 0\\.016487697076850806\ \(0\)\
\-\ increasing\\:\\ 0\\.01644278143157141\ \(0\)\
\-\ induration\\:\\ 0\\.016125841020918276\ \(0\)\
\-\ fasting\\:\\ 0\\.016125841020918276\ \(0\)\
\-\ incisional\\:\\ 0\\.016125841020918276\ \(0\)\
\-\ eosinophilia\\:\\ 0\\.015812387047621272\ \(0\)\
\-\ fibroblasts\\:\\ 0\\.015812387047621272\ \(0\)\
\-\ titer\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ kinase\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ monoclonal\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ peaks\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ numbers\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ usaf\\:\\ 0\\.015288575894301533\ \(0\)\
\-\ tightness\\:\\ 0\\.015288575894301533\ \(0\)\
\-\ mononucleosis\\:\\ 0\\.015288575894301533\ \(0\)\
\-\ hemolytic\\:\\ 0\\.01486059101919835\ \(0\)\
\-\ sweat\\:\\ 0\\.014672697339213524\ \(0\)\
\-\ strep\\:\\ 0\\.01449873496326582\ \(0\)\
\-\ chest\\:\\ 0\\.014399500000405062\ \(0\)\
\-\ mucin\\:\\ 0\\.014336779865878611\ \(0\)\
\-\ fs\\:\\ 0\\.014336779865878611\ \(0\)\
\-\ maj\\:\\ 0\\.014185280989968818\ \(0\)\
\-\ no\\:\\ 0\\.014138753650062475\ \(0\)\
\-\ bundles\\:\\ 0\\.014042969671150898\ \(0\)\
\-\ electrolytes\\:\\ 0\\.013908794990775433\ \(0\)\
\-\ beta\\:\\ 0\\.013908794990775433\ \(0\)\
\-\ buttocks\\:\\ 0\\.013661469836649077\ \(0\)\
\-\ spared\\:\\ 0\\.013661469836649077\ \(0\)\
\-\ ana\\:\\ 0\\.013661469836649077\ \(0\)\
\-\ stains\\:\\ 0\\.013661469836649077\ \(0\)\
\-\ separated\\:\\ 0\\.013546938934842899\ \(0\)\
\-\ \\:\\:\\ 0\\.013266136337918602\ \(0\)\
\-\ follicular\\:\\ 0\\.013233484961545897\ \(0\)\
\-\ eight\\:\\ 0\\.013137658683329338\ \(0\)\
\-\ papules\\:\\ 0\\.01304559128156107\ \(0\)\
\-\ enzymes\\:\\ 0\\.01304559128156107\ \(0\)\
\-\ special\\:\\ 0\\.01304559128156107\ \(0\)\
\-\ dermis\\:\\ 0\\.012871628905613367\ \(0\)\
\-\ performing\\:\\ 0\\.012789254915446066\ \(0\)\
\-\ l\\.\\:\\ 0\\.012709673808226156\ \(0\)\
\-\ iron\\:\\ 0\\.012632702393148714\ \(0\)\
\-\ maintained\\:\\ 0\\.012558174932316365\ \(0\)\
\-\ contact\\:\\ 0\\.012415863613498444\ \(0\)\
\-\ activities\\:\\ 0\\.012415863613498444\ \(0\)\
\-\ monitored\\:\\ 0\\.01209379525313815\ \(0\)\
\-\ documented\\:\\ 0\\.012034363778996623\ \(0\)\
\-\ there\\:\\ 0\\.011940991140516326\ \(0\)\
\-\ glands\\:\\ 0\\.011919832877190445\ \(0\)\
\-\ abdomen\\:\\ 0\\.011884433159134724\ \(0\)\
\-\ connective\\:\\ 0\\.011810630962554547\ \(0\)\
\-\ mc\\:\\ 0\\.011757877779803236\ \(0\)\
\-\ speech\\:\\ 0\\.011557976821257915\ \(0\)\
\-\ two\\:\\ 0\\.011489818016976553\ \(0\)\
\-\ collagen\\:\\ 0\\.011418485223908616\ \(0\)\
\-\ swallowing\\:\\ 0\\.011286819809234806\ \(0\)\
\-\ 1997\\:\\ 0\\.011244522847960913\ \(0\)\
\-\ histopathology\\:\\ 0\\.011202974544910677\ \(0\)\
\-\ seminar\\:\\ 0\\.011162148857793614\ \(0\)\
\-\ bun\\:\\ 0\\.011082567750573704\ \(0\)\
\-\ uniformed\\:\\ 0\\.011043766572284477\ \(0\)\
\-\ months\\:\\ 0\\.010957470867089519\ \(0\)\
\-\ presented\\:\\ 0\\.010935951338133377\ \(0\)\
\-\ sharp\\:\\ 0\\.010858834934131626\ \(0\)\
\-\ services\\:\\ 0\\.010823534752524724\ \(0\)\
\-\ dermatology\\:\\ 0\\.010823534752524724\ \(0\)\
\-\ continue\\:\\ 0\\.010823534752524724\ \(0\)\
\-\ glucose\\:\\ 0\\.010720711694641172\ \(0\)\
\-\ culture\\:\\ 0\\.010687414429401838\ \(0\)\
\-\ thick\\:\\ 0\\.010527664515681144\ \(0\)\
\-\ evidence\\:\\ 0\\.010518509781065154\ \(0\)\
\-\ protein\\:\\ 0\\.010292726819537992\ \(0\)\
\-\ feet\\:\\ 0\\.010264946402526249\ \(0\)\
\-\ over\\:\\ 0\\.010214284460750999\ \(0\)\
\-\ esr\\:\\ 0\\.010157000127310701\ \(0\)\
\-\ patient\\:\\ 0\\.010053895902774506\ \(0\)\
\-\ by\\:\\ 0\\.010020217628485035\ \(0\)\
\-\ five\\:\\ 0\\.010003853362361403\ \(0\)\
\-\ diabetes\\:\\ 0\\.00993087076360546\ \(0\)\
\-\ definitive\\:\\ 0\\.009907038905708706\ \(0\)\
\-\ spaces\\:\\ 0\\.009883446568024428\ \(0\)\
\-\ erythema\\:\\ 0\\.009860088983862062\ \(0\)\
\-\ six\\:\\ 0\\.009860088983862062\ \(0\)\
\-\ physical\\:\\ 0\\.009842747744512857\ \(0\)\
\-\ complaining\\:\\ 0\\.009791379166256164\ \(0\)\
\-\ denied\\:\\ 0\\.009768915666218252\ \(0\)\
\-\ serum\\:\\ 0\\.009681151506425716\ \(0\)\
\-\ 23\\:\\ 0\\.009535042800141159\ \(0\)\
\-\ noted\\:\\ 0\\.009509019664096684\ \(0\)\
\-\ able\\:\\ 0\\.00945546169292125\ \(0\)\
\-\ slight\\:\\ 0\\.009435980935140274\ \(0\)\
\-\ improvement\\:\\ 0\\.009359635414704689\ \(0\)\
\-\ regular\\:\\ 0\\.009249580048744946\ \(0\)\
\-\ posterior\\:\\ 0\\.009247129336631214\ \(0\)\
\-\ having\\:\\ 0\\.009214012431325691\ \(0\)\
\-\ symmetric\\:\\ 0\\.009161651498193537\ \(0\)\
\-\ overlying\\:\\ 0\\.009076897966169789\ \(0\)\
\-\ healthy\\:\\ 0\\.009043835196494345\ \(0\)\
\-\ lower\\:\\ 0\\.00902282661673175\ \(0\)\
\-\ thickened\\:\\ 0\\.008995098127366577\ \(0\)\
\-\ cbc\\:\\ 0\\.0089631599770009\ \(0\)\
\-\ difficulty\\:\\ 0\\.008931650539601509\ \(0\)\
\-\ clinically\\:\\ 0\\.008794869065132082\ \(0\)\
\-\ lateral\\:\\ 0\\.008669803031101176\ \(0\)\
\-\ full\\:\\ 0\\.008665620761885538\ \(0\)\
\-\ infectious\\:\\ 0\\.008624072458835301\ \(0\)\
\-\ down\\:\\ 0\\.008610384852471937\ \(0\)\
\-\ but\\:\\ 0\\.00855635352597905\ \(0\)\
\-\ before\\:\\ 0\\.00849066054624571\ \(0\)\
\-\ involved\\:\\ 0\\.008414107528431717\ \(0\)\
\-\ arm\\:\\ 0\\.008401587936940257\ \(0\)\
\-\ around\\:\\ 0\\.008352166788588538\ \(0\)\
\-\ history\\:\\ 0\\.0083113699838527\ \(0\)\
\-\ line\\:\\ 0\\.008244632666449349\ \(0\)\
\-\ family\\:\\ 0\\.008221390715785705\ \(0\)\
\-\ range\\:\\ 0\\.008075680789395148\ \(0\)\
\-\ motion\\:\\ 0\\.008064838193488353\ \(0\)\
\-\ sounds\\:\\ 0\\.008000813738277886\ \(0\)\
\-\ worsening\\:\\ 0\\.007897840306105158\ \(0\)\
\-\ \\#\\:\\ 0\\.007867808964649973\ \(0\)\
\-\ marked\\:\\ 0\\.007828355635268795\ \(0\)\
\-\ laboratory\\:\\ 0\\.0073922341217231595\ \(0\)\
\-\ involvement\\:\\ 0\\.007351968677530085\ \(0\)\
\-\ later\\:\\ 0\\.007242766762894187\ \(0\)\
\-\ otherwise\\:\\ 0\\.007204965336681561\ \(0\)\
\-\ biopsy\\:\\ 0\\.007116650801964227\ \(0\)\
\-\ heart\\:\\ 0\\.00696967053734454\ \(0\)\
\-\ liver\\:\\ 0\\.006916012936227051\ \(0\)\
\-\ presentation\\:\\ 0\\.006909391160777188\ \(0\)\
\-\ elevated\\:\\ 0\\.006805906951547096\ \(0\)\
\-\ areas\\:\\ 0\\.006749641247056495\ \(0\)\
\-\ extending\\:\\ 0\\.006743471945633327\ \(0\)\
\-\ available\\:\\ 0\\.006743471945633327\ \(0\)\
\-\ followed\\:\\ 0\\.006725060730936083\ \(0\)\
\-\ initial\\:\\ 0\\.006646906439622789\ \(0\)\
\-\ positive\\:\\ 0\\.006509121103953326\ \(0\)\
\-\ revealed\\:\\ 0\\.0064377321358359\ \(0\)\
\-\ between\\:\\ 0\\.006357970742310431\ \(0\)\
\-\ and\\:\\ 0\\.006338345272261213\ \(0\)\
\-\ any\\:\\ 0\\.006316514162141534\ \(0\)\
\-\ approximately\\:\\ 0\\.006206145132759584\ \(0\)\
\-\ tenderness\\:\\ 0\\.006100733152304303\ \(0\)\
\-\ diffuse\\:\\ 0\\.00607278737177304\ \(0\)\
\-\ month\\:\\ 0\\.006017874508921619\ \(0\)\
\-\ negative\\:\\ 0\\.0059908923975936015\ \(0\)\
\-\ decreased\\:\\ 0\\.00596421690780413\ \(0\)\
\-\ infection\\:\\ 0\\.005831024821767153\ \(0\)\
\-\ weeks\\:\\ 0\\.005693140274415841\ \(0\)\
\-\ been\\:\\ 0\\.005457264998741764\ \(0\)\
\-\ significant\\:\\ 0\\.0053940073968409\ \(0\)\
\-\ due\\:\\ 0\\.005352763269842346\ \(0\)\
\-\ anterior\\:\\ 0\\.005166180337471214\ \(0\)\
\-\ \\(\\:\\ 0\\.005087054410168032\ \(0\)\
\-\ \\)\\:\\ 0\\.005024913324741585\ \(0\)\
\-\ consistent\\:\\ 0\\.004918540537162449\ \(0\)\
\-\ increased\\:\\ 0\\.004907241271830178\ \(0\)\
\-\ tissue\\:\\ 0\\.004754509832048342\ \(0\)\
\-\ without\\:\\ 0\\.0047230356017797185\ \(0\)\
\-\ \\'s\\:\\ 0\\.004422644644054096\ \(0\)\
\-\ exam\\:\\ 0\\.004406652441196099\ \(0\)\
\-\ case\\:\\ 0\\.004388508058373875\ \(0\)\
\-\ large\\:\\ 0\\.00438624983997906\ \(0\)\
\-\ had\\:\\ 0\\.00432828596065894\ \(0\)\
\-\ findings\\:\\ 0\\.004269570271807417\ \(0\)\
\-\ after\\:\\ 0\\.004150237564810334\ \(0\)\
\-\ treatment\\:\\ 0\\.004060133707983303\ \(0\)\
\-\ seen\\:\\ 0\\.003963914589360775\ \(0\)\
\-\ also\\:\\ 0\\.0039545060884275856\ \(0\)\
\-\ disease\\:\\ 0\\.0032787266225720755\ \(0\)\
\-\ of\\:\\ 0\\.0030083141051123773\ \(0\)\
\-\ to\\:\\ 0\\.003007521890443565\ \(0\)\
\-\ a\\:\\ 0\\.0027929563508352203\ \(0\)\
\-\ the\\:\\ 0\\.0025962306986596394\ \(0\)\
\-\ or\\:\\ 0\\.002350992368459407\ \(0\)\
\-\ \\.\\:\\ 0\\.0022499705977191303\ \(0\)\
\-\ left\\:\\ 0\\.0022443785663683446\ \(0\)\
\-\ for\\:\\ 0\\.0017115214756871248\ \(0\)\
\-\ on\\:\\ 0\\.0016992746769141504\ \(0\)\
\-\ is\\:\\ 0\\.0013199314046589805\ \(0\)\
\-\ with\\:\\ 0\\.0010986307614074154\ \(0\)\
\-\ in\\:\\ 0\\.0009891953759160914\ \(0\)\
